Latest Content

More short-term injections were needed to maintain visual outcomes in patients who lost their co-payment assistance.

Aficamten improved exercise capacity across submaximal, peak, and recovery measures.

These phase 3 studies are evaluating outcomes among patients living with polycythemia vera, myelofibrosis, and essential thrombocythemia.

Investigators described the combinations as a potential new standard of care in second-line HR+/HER2− advanced breast cancer.

Texas abortion ban worsens maternal mental health; SCD trials exclude 90% of adults; nutrition, hepatitis B, and cost-control gaps persist.

A new study finds Texas's abortion ban raised the likelihood of poor maternal mental health by 2.5 points—and 7 points for mothers on Medicaid.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

EHA 2026 highlights included practice-changing immunotherapy data in relapsed/refractory multiple myeloma and high-risk pediatric B-cell ALL, plus insights on childhood cancer predisposition.

Experts at ADA 2026 say nutrition guidelines must be personalized, culturally responsive, and built on research that reflects the patients they're meant to serve.